The HCPLive pain page is a resource for medical news and expert insights on pain medicine. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for acute pain, chronic pain, addiction medicine, and more.
April 29th 2024
FDA issued a CRL the abbreviated new drug application of ketamine, which had sought to enhance accessibility to the limited drug supply.
Advancing Care in Erosive Esophagitis: Towards a Path of Complete Healing
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Obesity and Chronic Pain Linked
July 23rd 2010Researchers from the University of California San Diego, University of Washington and Veterans' Affairs San Diego Healthcare System evaluated the influence of family history and psychological factors on the relationship between obesity and chronic pain. The team used data from large community-based samples of twins.
Oral Calcitonin Product Advances
July 23rd 2010The ORACAL trial of Tarsa Therapeutics, Inc.'s oral calcitonin product has completed patient enrollment in a multinational, randomized, double-blind, placebo-controlled Phase III trial. The product is for the treatment of postmenopausal osteoporosis. Additionally, the trial completed two separate safety reviews of patient data by an independent data monitoring committee and is set to proceed as planned.
Arthritic Knee Patients May Benefit from Procedure that Incorporates Stem Cells
July 22nd 2010Findings from one of the longest and largest studies on biologic knee joint repair were release by The Stone Research Foundation and published in the July issue of The British Journal of Bone & Joint Surgery.
Study Reveals Cheaper Method of Uncovering Potential ACL Injuries
July 19th 2010Physicians may have a new low-cost, in-office, tool to help identify athletes at increased risk for ACL injuries, according to study results presented at the American Orthopaedic Society for Sports Medicine's Annual Meeting.
Nanobead Technology Can Speed Up Drug Discovery
July 16th 2010The future of drug testing may come to include the use of nanoscopic beads that can match a drug to a disease marker and uncover viable treatments, if the results of a study published in the Journal of Molecular Recognition are taken into consideration.
Addex Drug for Osteoarthritis Pain to Begin Clinical Trials
July 13th 2010A drug being tested for osteoarthritis pain has proven effective in a model of OA pain. Manufactured by Addex Pharmaceuticals Ltd., ADX71943 modulates gamma-aminobutyric acid subtype B (GABA-B) receptors. These receptors are implicated in pain processing.
FDA's Long-acting Opioid REMS Proposal to Focus on CME
July 12th 2010On July 22-23 The FDA will convene a joint meeting of the Anesthetic & Life Support Drugs Advisory Committee and the Drug Safety & Risk Management Advisory committee to discuss its proposal for class-wide Risk Evaluation Mitigation Strategies for long-acting opioids, according to a memo released earlier this month.